Gilberg Erik, Stumpfe Dagmar, Bajorath Jürgen
Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Dahlmannstr. 2, D-53113 Bonn, Germany.
Pharmaceutical Institute, Rheinische Friedrich-Wilhelms-Universität, An der Immenburg 4, D-53121 Bonn, Germany.
ACS Omega. 2018 Jan 31;3(1):106-111. doi: 10.1021/acsomega.7b01849. Epub 2018 Jan 5.
Compounds with multitarget activity (promiscuity) are increasingly sought in drug discovery. However, promiscuous compounds are often viewed controversially in light of potential assay artifacts that may give rise to false-positive activity annotations. We have reasoned that the strongest evidence for true multitarget activity of small molecules would be provided by experimentally determined structures of ligand-target complexes. Therefore, we have carried out a systematic search of currently available X-ray structures for compounds forming complexes with different targets. Rather unexpectedly, 1418 such crystallographic ligands were identified, including 702 that formed complexes with targets from different protein families (multifamily ligands). About half of these multifamily ligands originated from the medicinal chemistry literature, making it possible to consider additional target annotations and search for analogues. From 168 distinct series of analogues containing one or more multifamily ligands, 133 unique analogue-series-based scaffolds were isolated that can serve as templates for the design of new compounds with multitarget activity. As a part of our study, all of the multifamily ligands we have identified and the analogue-series-based scaffolds are made freely available.
在药物研发中,具有多靶点活性(混杂性)的化合物越来越受到关注。然而,鉴于可能导致假阳性活性注释的潜在检测假象,混杂性化合物常常受到争议。我们推断,小分子真正多靶点活性的最有力证据将来自于实验确定的配体-靶点复合物结构。因此,我们对目前可用的X射线结构进行了系统搜索,以寻找与不同靶点形成复合物的化合物。相当出乎意料的是,我们鉴定出了1418种这样的晶体学配体,其中包括702种与来自不同蛋白质家族的靶点形成复合物的配体(多家族配体)。这些多家族配体中约有一半来自药物化学文献,这使得考虑额外的靶点注释并搜索类似物成为可能。从包含一个或多个多家族配体的168个不同系列类似物中,分离出了133种基于独特类似物系列的支架,这些支架可作为设计具有多靶点活性新化合物的模板。作为我们研究的一部分,我们鉴定出的所有多家族配体以及基于类似物系列的支架均可免费获取。